{
    "2020-09-23": [
        [
            {
                "time": "",
                "original_text": "贝达药业「埃克替尼」新适应症报上市 用于术后辅助治疗",
                "features": {
                    "keywords": [
                        "贝达药业",
                        "埃克替尼",
                        "新适应症",
                        "术后辅助治疗"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "贝达药业(300558)：辅助治疗新适应症报产 埃克替尼继续绽放",
                "features": {
                    "keywords": [
                        "贝达药业",
                        "埃克替尼",
                        "辅助治疗",
                        "新适应症",
                        "报产"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            }
        ]
    ]
}